"EB Medical Research is een onafhankelijk medisch onderzoekscentrum dat geneesmiddelenonderzoek uitvoert in opdracht van farmaceutische bedrijven, ziekenhuizen of andere onderzoeksinstellingen."

During the past decade, EB Flevoresearch conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "EB Flevoresearch" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "CLJI Worldwide" with 1 trials sponsored, "HAL Allergy" with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "EB Flevoresearch" #1 collaborator was "Applied Clinical Services BV" with 1 trials as a collaborator, "EB FlevoResearch BV" with 1 trials as a collaborator, "EB Medical Research" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "PreCare Trial & Recruitment B.V." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "EB Flevoresearch" are "Cardiovascular Disease" (2 trials), "Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "EB Flevoresearch" in a lesser frequency.

Most popular intervention types in "EB Flevoresearch" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Atomoxetine hydrochloride" (1 trials), "BI 456906" (1 trials) and "G3P-01" (1 trials). Other intervention names were less common.

The vast majority of trials in "EB Flevoresearch" are 9 trials for "All" genders.

Currently, there are NaN active trials in "EB Flevoresearch". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in EB Flevoresearch, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in EB Flevoresearch, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".